
Stem Cell Reviews and Reports (SCRR) covers contemporary and emerging areas in stem cells by publication of reviews, original data reports (full reports and short reports), protocols, novel hypotheses and commentaries. The scope related to stem cells is broad and includes topics in stem cell biology covering basic, clinical, biotechnology, regulatory, and ethical aspects of embryonic and adult stem cells, induced pluripotent stem cells, fate choice, specific lineage and cloning issues, translational studies, and diseases where stem cell anomalies play a key role and related matters. Original articles are expected to provide novel insights based on new data. Reviews, commentaries and hypotheses should provide syntheses of current concepts in the field and discuss emerging issues and controversies; the nature of the topic or idea being discussed will dictate appropriate choice of article type. Protocols will help accelerate studies in the field, by providing practical and step by step descriptions of established or emerging protocols and techniques of utility for both established and novice investigator.
In 2009, Stem Cell Reviews changed its title to Stem Cell Reviews and Reports. Each journal name was issued a separate 2010 Impact Factor but the correct, combined 2010 Impact Factor is 3.766.
- Thorough coverage of emerging issues in stem cells
- Includes embryonic and adult stem cells, and related lineage and cloning concerns
- Presents reviews covering clinical, regulatory and ethical aspects of stem cells
Journal information
- Editor-in-Chief
-
- Mariusz Z. Ratajczak
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 5.316 (2019)
- Impact factor
- 4.538 (2019)
- Five year impact factor
- 22 days
- Submission to first decision
- 75 days
- Submission to acceptance
- 171,644 (2019)
- Downloads
Latest issue
Latest articles
-
-
Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs
Authors (first, second and last of 4)
-
-
Stem Cells as Potential Therapeutics and Targets for Infection by COVID19 – Special Issue on COVID19 in Stem Cell Reviews and Reports
Authors
This is part of 1 collection: -
Latent Membrane Protein 1 Promotes Tumorigenesis Through Upregulation of PGC1β Signaling Pathway
Authors (first, second and last of 7)
Journal updates
-
Call for Papers
Stem Cell Reviews and Reports is inviting submissions to the following special thematic issues:
Neurogenesis and Neurodegeneration: basic research and clinic applications
Exosomes & Microvesicles: from Stem Cell biology to translation in human diseases
-
-
About this journal
- Electronic ISSN
- 2629-3277
- Print ISSN
- 2629-3269
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- CNKI
- Chemical Abstracts Service (CAS)
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- EMBiology
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Genetics Abstracts
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Neurosciences Abstracts
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature